Back

Pharmacokinetics of furosemide following subcutaneous administration of a novel injectable formulation.

21 May 2016 (13:00 - 13:15)
Organised by:
Congress Presentation Part of: Furosemide 2.0: furosemide for subcutaneous administration: a novel tool in the management of the pre and post acute heart failure patient Acute Heart Failure HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Rudolf De Boer

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Furosemide 2.0: a novel formulation of furosemide for subcutaneous administration.
Professor B. Pitt (Ann Arbor, US)
Presentation thumbnail
Initial clinical experience with subcutaneous furosemide in patients with fluid overload.
Doctor S. Russell (Durham, US)
Presentation thumbnail
Rationale for and design of the SUBQ-HF clinical study.
Professor G. Felker (Durham, US)

Access the full session

Session thumbnail
Furosemide 2.0: furosemide for subcutaneous administration: a novel tool in the management of the pre and post acute heart failure patient

The Event

Event poster

HEART FAILURE 2016

21 May 2016 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Natriuretic response following an infusion of subcutaneous furosemide in patients with worsening heart failure
29 June 2021
thumbnail
Webinar
Injectable therapies for cardiovascular disease: optimising their use in practice - experiences from the UK and Italy
18 March 2022
thumbnail
Congress Presentation
The complete bioavailability of asundexian is unaffected by tablet formulation, gastric pH or food
29 August 2022
thumbnail
Congress Presentation
Vericiguat clinical pharmacology programme: biopharmaceutical properties and potential intrinsic and extrinsic factor effects
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources